Clinical Research Directory
Browse clinical research sites, groups, and studies.
Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment
Sponsor: Chinese University of Hong Kong
Summary
To determine if the use of Buscopan in patients undergoing IVF/ICSI treatment with high uterine contraction frequency prior to embryo transfer has a higher live birth rate.
Official title: Use of Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment With High and Low Uterine Contraction Frequency Prior to Embryo Transfer: A Prospective Double-blinded Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
Any - 42 Years
Study Type
INTERVENTIONAL
Enrollment
675
Start Date
2020-05-30
Completion Date
2024-09-14
Last Updated
2024-05-08
Healthy Volunteers
No
Conditions
Interventions
Buscopan 20 milligrams/ML Injectable Solution
cases will be randomized to Buscopan group or Normal Saline group, injection will be given 5 minutes prior to embryo transfer
Locations (1)
Prince of Wales Hospital
Hong Kong, Hong Kong